NCT04827875View on ClinicalTrials.gov

Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
KeloidScarIncisionExcision Margin
Interventions
DRUG

AIV001

Intradermal

Trial Locations (4)

33146

Skin Research Institute, Coral Gables

77845

J&S Studies, College Station

78759

DermResearch DRI, Austin

92024

California Dermatology & Clinical Research Institute, Encinitas

Sponsors
All Listed Sponsors
lead

AiViva BioPharma, Inc.

INDUSTRY

NCT04827875 - Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy | Biotech Hunter | Biotech Hunter